Sugar intake deepened gut disruption during antibiotics
In a study of patients hospitalized for blood stem-cell transplantation, sweets consumed during antibiotic treatment were linked to a sharper loss of gut bacterial diversity and more Enterococcus. Researchers tracked 9,419 meals and paired diets with stool samples; adding sugar in a separate mouse experiment prolonged a similar bacterial expansion. The patient results are observational, so they do not establish that restricting sugar improves treatment outcomes.
Science··Night
Meals and gut samples tracked together
A peer-reviewed Nature study examined how diet and antibiotics intersect during blood stem-cell transplantation. NYU Langone Health, one of the participating research institutions, separately reported the same study and its central sugar finding on September 30. The team recorded 9,419 meals eaten by 173 hospitalized people, then matched daily food information to stool samples taken over time. This setting matters because transplantation patients commonly receive chemotherapy and antibiotics, both of which can disturb the community of microbes in the gut. Repeated microbiome samples from 158 patients entered the statistical analysis. The investigators could therefore compare diet and microbial change during treatment, but patients were not randomly assigned to eat different amounts of sugar.[1], [2]
Enterococcus expanded during treatment
During antibiotic exposure, patients eating more sweets and simple sugars tended to lose more bacterial diversity. Enterococcus, a bacterial group that can include difficult-to-treat hospital pathogens, also expanded more in the human data. The finding is about changes in microbial composition, not a demonstrated rise in infections caused by one meal. Severe illness, treatment intensity, appetite and other dietary changes may influence what patients eat and what appears in their samples. The observational comparison cannot isolate sugar as the sole cause of the human pattern. It nevertheless points to diet as a factor worth examining alongside antibiotics, rather than treating the drugs as the only influence on the gut environment.[1]
Mouse intervention tested the pattern
To probe that relationship, the researchers gave sugar to mice exposed to antibiotics. Enterococcus grew more and remained elevated longer than in comparison mice, an intervention that lends biological support to the human association. The mouse experiment cannot establish that a sugar-restricted diet prevents infection or improves survival in transplant patients. Nor was such a diet tested as a clinical intervention in the patient group. The next question is whether controlled dietary changes alter microbial recovery or health outcomes while people undergo intensive treatment. For now, the study describes a measured association in hospitalized patients and a related experimental response in mice, with their different levels of evidence kept separate.[1]
